Literature DB >> 8572031

Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis.

J A Jordan1.   

Abstract

OBJECTIVE: This retrospective study was designed to determine the incidence of B19 associated with idiopathic nonimmune hydrops fetalis by use of a sensitive molecular tool, the polymerase chain reaction assay. STUDY
DESIGN: Placental and fetal tissues from 57 cases of nonimmune hydrops fetalis were analyzed for B19 deoxyribonucleic acid. Thirty-four of these cases were classified as idiopathic. The remaining 23 cases had known, noninfectious-based causes.
RESULTS: Eighteen percent of all cases (6/34) of idiopathic nonimmune hydrops fetalis contained B19 deoxyribonucleic acid. In contrast, none of the 23 cases of known, noninfectious-based nonimmune hydrops fetalis examined contained any B19 deoxyribonucleic acid. Presence of the virus was confirmed in each of the six cases by either B19-specific deoxyribonucleic acid in situ hybridization or immunocytochemistry. However, histologic examination was unsuccessful at detecting characteristic viral-like inclusions in one third of the cases.
CONCLUSION: Eighteen percent of cases of idiopathic nonimmune hydrops fetalis contained B19 deoxyribonucleic acid. This significant finding demonstrates the usefulness of polymerase chain reaction to aid in the differential diagnosis of this disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8572031     DOI: 10.1016/s0002-9378(96)70370-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.

Authors:  J A Jordan
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Comparison of 16S rRNA gene PCR and BACTEC 9240 for detection of neonatal bacteremia.

Authors:  J A Jordan; M B Durso
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women.

Authors:  Allyson R Butchko; Jeanne A Jordan
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 4.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

5.  Placental cellular immune response in women infected with human parvovirus B19 during pregnancy.

Authors:  J A Jordan; D Huff; J A DeLoia
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Detection of parvovirus B19 in macerated fetal tissue using in situ hybridisation.

Authors:  C Walters; D G Powe; C J Padfield; D G Fagan
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

7.  Parvovirus B19 in anemic liver transplant recipients.

Authors:  O K Ndimbie; E Frezza; J A Jordan; W Koch; D H van Thiel
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

8.  Prevalence of antibodies to human parvovirus b19 in saudi women of childbearing age in makkah.

Authors:  Hani O Ghazi
Journal:  J Family Community Med       Date:  2007-01

9.  Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.

Authors:  Carole C Wegner; Jeanne A Jordan
Journal:  Infect Dis Obstet Gynecol       Date:  2004-06

10.  Assessment of Diagnostic Yield of Nonculture Infection Testing on Cerebrospinal Fluid in Immune-Competent Children.

Authors:  Jennifer L McGuire; Nichole V Tuite; Sanjeev K Swami; Robert A Avery
Journal:  JAMA Netw Open       Date:  2019-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.